Head of Global Business Development at Biovian
Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space. Prior to joining Biovian, Magnus worked at Cytiva (formerly GE Healthcare Life Sciences) as Director Strategy Search and Evaluation and at Cobra Biologics as Business and Corporate Development Director. Magnus has a scientific background, with more than 20 peer-reviewed articles, and has spent 15 years in various commercial positions executing intra- and extra scientific and corporate collaborations, sales management, project management, business development, partnership negotiations and agreements. Magnus holds an MSc in Biochemical Engineering, a PhD in Medical Biochemistry and Biophysics and an MBA in Business Administration
Title: Closed process for aseptic fill without possibility for sterile filtration
- Biovian has established several expert fill processes to accommodate aseptic fill finish of valuable drugs and non-sterile filterable drugs with minimal in-line losses. This talk will in particular focus on a closed process for aseptic fill of vaccines, for which sterile filtering is not possible due to the size of the Vaccine modality.
- The talk will also include feasibility, installation and commissioning of Biovian's new state of the art fill line and it will include fill of BLS2 fill of viruses and viral vectors.